# ProtoMedX: Towards Explainable Multi-Modal Prototype Learning for Bone Health Classification

**Korean Title:** ProtoMedX: ê³¨ ê±´ê°• ë¶„ë¥˜ë¥¼ ìœ„í•œ ì„¤ëª… ê°€ëŠ¥í•œ ë‹¤ì¤‘ ëª¨ë‹¬ í”„ë¡œí† íƒ€ì… í•™ìŠµì„ í–¥í•˜ì—¬

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily/2025-09-18|2025-09-18]] [[authors/Alvaro Lopez Pellicer|Alvaro Lopez Pellicer]] [[authors/Andre Mariucci|Andre Mariucci]] [[authors/Plamen Angelov|Plamen Angelov]] [[authors/Marwan Bukhari|Marwan Bukhari]] [[authors/Jemma G. Kerns|Jemma G. Kerns]] [[categories/cs.AI|cs.AI]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸš€ Evolved Concepts**: Explainable AI

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[Mixture of Multicenter Experts in Multimodal AI for Debiased Radiotherapy Target Delineation_20250919|Mixture of Multicenter Experts in Multimodal AI for Debiased Radiotherapy Target Delineation]] (82.8% similar)
- [[Blockchain-Enabled Explainable AI for Trusted Healthcare Systems_20250918|Blockchain-Enabled Explainable AI for Trusted Healthcare Systems]] (82.2% similar)
- [[Fine-tuning Vision Language Models with Graph-based Knowledge for Explainable Medical Image Analysis_20250919|Fine-tuning Vision Language Models with Graph-based Knowledge for Explainable Medical Image Analysis]] (80.9% similar)
- [[Explainable AI for Infection Prevention and Control_ Modeling CPE Acquisition and Patient Outcomes in an Irish Hospital with Transformers_20250918|Explainable AI for Infection Prevention and Control Modeling CPE Acquisition and Patient Outcomes in an Irish Hospital with Transformers]] (80.6% similar)
- [[Taylor-Series Expanded Kolmogorov-Arnold Network for Medical Imaging Classification_20250918|Taylor-Series Expanded Kolmogorov-Arnold Network for Medical Imaging Classification]] (80.5% similar)

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** Alvaro Lopez Pellicer, Andre Mariucci, Plamen Angelov, Marwan Bukhari, Jemma G. Kerns

## ğŸ“„ Abstract (ì›ë¬¸)

Bone health studies are crucial in medical practice for the early detection
and treatment of Osteopenia and Osteoporosis. Clinicians usually make a
diagnosis based on densitometry (DEXA scans) and patient history. The
applications of AI in this field are ongoing research. Most successful methods
rely on deep learning models that use vision alone (DEXA/X-ray imagery) and
focus on prediction accuracy, while explainability is often disregarded and
left to post hoc assessments of input contributions. We propose ProtoMedX, a
multi-modal model that uses both DEXA scans of the lumbar spine and patient
records. ProtoMedX's prototype-based architecture is explainable by design,
which is crucial for medical applications, especially in the context of the
upcoming EU AI Act, as it allows explicit analysis of model decisions,
including incorrect ones. ProtoMedX demonstrates state-of-the-art performance
in bone health classification while also providing explanations that can be
visually understood by clinicians. Using a dataset of 4,160 real NHS patients,
the proposed ProtoMedX achieves 87.58% accuracy in vision-only tasks and 89.8%
in its multi-modal variant, both surpassing existing published methods.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

ë¼ˆ ê±´ê°• ì—°êµ¬ëŠ” ê³¨ê°ì†Œì¦ê³¼ ê³¨ë‹¤ê³µì¦ì˜ ì¡°ê¸° ë°œê²¬ ë° ì¹˜ë£Œë¥¼ ìœ„í•´ ì˜ë£Œ ì‹¤ë¬´ì—ì„œ ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤. ì„ìƒì˜ë“¤ì€ ì¼ë°˜ì ìœ¼ë¡œ ê³¨ë°€ë„ ì¸¡ì •(DEXA ìŠ¤ìº”)ê³¼ í™˜ì ê¸°ë¡ì„ ë°”íƒ•ìœ¼ë¡œ ì§„ë‹¨ì„ ë‚´ë¦½ë‹ˆë‹¤. ì´ ë¶„ì•¼ì—ì„œ ì¸ê³µì§€ëŠ¥(AI)ì˜ ì‘ìš©ì€ í˜„ì¬ ì§„í–‰ ì¤‘ì¸ ì—°êµ¬ì…ë‹ˆë‹¤. ëŒ€ë¶€ë¶„ì˜ ì„±ê³µì ì¸ ë°©ë²•ì€ ì‹œê° ì •ë³´(DEXA/X-ray ì´ë¯¸ì§€)ë§Œì„ ì‚¬ìš©í•˜ëŠ” ë”¥ëŸ¬ë‹ ëª¨ë¸ì— ì˜ì¡´í•˜ë©°, ì˜ˆì¸¡ ì •í™•ì„±ì— ì¤‘ì ì„ ë‘ê³  ì„¤ëª… ê°€ëŠ¥ì„±ì€ ì¢…ì¢… ë¬´ì‹œë˜ê±°ë‚˜ ì…ë ¥ ê¸°ì—¬ë„ì˜ ì‚¬í›„ í‰ê°€ì— ë§¡ê²¨ì§‘ë‹ˆë‹¤. ìš°ë¦¬ëŠ” ìš”ì¶”ì˜ DEXA ìŠ¤ìº”ê³¼ í™˜ì ê¸°ë¡ì„ ëª¨ë‘ ì‚¬ìš©í•˜ëŠ” ë‹¤ì¤‘ ëª¨ë‹¬ ëª¨ë¸ì¸ ProtoMedXë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. ProtoMedXì˜ í”„ë¡œí† íƒ€ì… ê¸°ë°˜ ì•„í‚¤í…ì²˜ëŠ” ì„¤ê³„ìƒ ì„¤ëª… ê°€ëŠ¥í•˜ë©°, ì´ëŠ” íŠ¹íˆ ë‹¤ê°€ì˜¤ëŠ” EU AI ë²•ì•ˆì˜ ë§¥ë½ì—ì„œ ëª¨ë¸ ê²°ì •, íŠ¹íˆ ì˜ëª»ëœ ê²°ì •ì— ëŒ€í•œ ëª…ì‹œì  ë¶„ì„ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ë¯€ë¡œ ì˜ë£Œ ì‘ìš©ì— ë§¤ìš° ì¤‘ìš”í•©ë‹ˆë‹¤. ProtoMedXëŠ” ë¼ˆ ê±´ê°• ë¶„ë¥˜ì—ì„œ ìµœì²¨ë‹¨ ì„±ëŠ¥ì„ ë³´ì—¬ì£¼ë©´ì„œë„ ì„ìƒì˜ë“¤ì´ ì‹œê°ì ìœ¼ë¡œ ì´í•´í•  ìˆ˜ ìˆëŠ” ì„¤ëª…ì„ ì œê³µí•©ë‹ˆë‹¤. 4,160ëª…ì˜ ì‹¤ì œ NHS í™˜ì ë°ì´í„°ì…‹ì„ ì‚¬ìš©í•˜ì—¬ ì œì•ˆëœ ProtoMedXëŠ” ì‹œê° ì •ë³´ë§Œì„ ì‚¬ìš©í•˜ëŠ” ì‘ì—…ì—ì„œ 87.58%ì˜ ì •í™•ë„ë¥¼, ë‹¤ì¤‘ ëª¨ë‹¬ ë³€í˜•ì—ì„œëŠ” 89.8%ì˜ ì •í™•ë„ë¥¼ ë‹¬ì„±í•˜ì—¬ ê¸°ì¡´ì— ë°œí‘œëœ ë°©ë²•ë“¤ì„ ëŠ¥ê°€í•©ë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ê³¨ë‹¤ê³µì¦ ë° ê³¨ê°ì†Œì¦ì˜ ì¡°ê¸° ë°œê²¬ê³¼ ì¹˜ë£Œë¥¼ ìœ„í•œ ë¼ˆ ê±´ê°• ì—°êµ¬ì—ì„œ ì¸ê³µì§€ëŠ¥(AI)ì˜ í™œìš©ì„ ë‹¤ë£¹ë‹ˆë‹¤. ê¸°ì¡´ ë°©ë²•ì€ ì£¼ë¡œ DEXA ìŠ¤ìº”ê³¼ í™˜ì ê¸°ë¡ì— ì˜ì¡´í•˜ì§€ë§Œ, ì„¤ëª… ê°€ëŠ¥ì„±ì´ ë¶€ì¡±í•œ ë¬¸ì œì ì´ ìˆìŠµë‹ˆë‹¤. ì´ë¥¼ í•´ê²°í•˜ê¸° ìœ„í•´ ì œì•ˆëœ ProtoMedXëŠ” DEXA ìŠ¤ìº”ê³¼ í™˜ì ê¸°ë¡ì„ ëª¨ë‘ ì‚¬ìš©í•˜ëŠ” ë‹¤ì¤‘ ëª¨ë‹¬ ëª¨ë¸ë¡œ, í”„ë¡œí† íƒ€ì… ê¸°ë°˜ ì•„í‚¤í…ì²˜ë¥¼ í†µí•´ ì„¤ëª… ê°€ëŠ¥ì„±ì„ ë‚´ì¬í™”í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” íŠ¹íˆ EU AI ë²•ì•ˆì— ëŒ€ë¹„í•´ ëª¨ë¸ì˜ ê²°ì • ê³¼ì •ì„ ëª…í™•íˆ ë¶„ì„í•  ìˆ˜ ìˆê²Œ í•´ì¤ë‹ˆë‹¤. ProtoMedXëŠ” 4,160ëª…ì˜ NHS í™˜ì ë°ì´í„°ë¥¼ ì‚¬ìš©í•˜ì—¬ 87.58%ì˜ ì •í™•ë„ë¥¼ ë³´ì˜€ìœ¼ë©°, ë‹¤ì¤‘ ëª¨ë‹¬ ë³€í˜•ì—ì„œëŠ” 89.8%ì˜ ì •í™•ë„ë¥¼ ê¸°ë¡í•˜ì—¬ ê¸°ì¡´ ë°©ë²•ì„ ëŠ¥ê°€í•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ê³¨ ê±´ê°• ì—°êµ¬ëŠ” ê³¨ê°ì†Œì¦ê³¼ ê³¨ë‹¤ê³µì¦ì˜ ì¡°ê¸° ë°œê²¬ ë° ì¹˜ë£Œì— ì¤‘ìš”í•˜ë‹¤.

- 2. AIì˜ ì ìš©ì€ ì§„í–‰ ì¤‘ì¸ ì—°êµ¬ë¡œ, ëŒ€ë¶€ë¶„ì˜ ì„±ê³µì ì¸ ë°©ë²•ì€ ì‹œê°ì  ë°ì´í„°ì— ì˜ì¡´í•˜ë©° ì„¤ëª… ê°€ëŠ¥ì„±ì€ ì¢…ì¢… ê°„ê³¼ëœë‹¤.

- 3. ProtoMedXëŠ” ìš”ì¶” DEXA ìŠ¤ìº”ê³¼ í™˜ì ê¸°ë¡ì„ ì‚¬ìš©í•˜ëŠ” ë‹¤ì¤‘ ëª¨ë‹¬ ëª¨ë¸ë¡œ, ì„¤ëª… ê°€ëŠ¥í•œ í”„ë¡œí† íƒ€ì… ê¸°ë°˜ ì•„í‚¤í…ì²˜ë¥¼ ì œê³µí•œë‹¤.

- 4. ProtoMedXëŠ” 4,160ëª…ì˜ NHS í™˜ì ë°ì´í„°ë¥¼ ì‚¬ìš©í•˜ì—¬ 87.58%ì˜ ì •í™•ë„ë¥¼ ë‹¬ì„±í•˜ë©°, ë‹¤ì¤‘ ëª¨ë‹¬ ë³€í˜•ì—ì„œëŠ” 89.8%ì˜ ì •í™•ë„ë¥¼ ê¸°ë¡í•œë‹¤.

- 5. ProtoMedXëŠ” ê³¨ ê±´ê°• ë¶„ë¥˜ì—ì„œ ìµœì²¨ë‹¨ ì„±ëŠ¥ì„ ë³´ì´ë©°, ì„ìƒì˜ê°€ ì´í•´í•  ìˆ˜ ìˆëŠ” ì‹œê°ì  ì„¤ëª…ì„ ì œê³µí•œë‹¤.

---

*Generated on 2025-09-20 02:49:07*